PBYI Puma Biotechnology Inc - Common Stock
$9,41
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 6, 2026
Zakres 52 tyg.
$4–$10
98% of range
Ocena Analityków
HOLD
6 analysts
Cena Docelowa
$6
P/E (TTM)
15.6
ROE
26.5%
Marża Zysku Netto
13.6%
O Puma Biotechnology Inc - Common Stock Przegląd firmy z Wikipedii
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
Czytaj więcej
Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.
Creation
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. This was the same business plan Auerbach had followed at Cougar Biotechnology, which he founded in 2003, and through which he in-licensed abiraterone acetate from BTG plc. Cougar further developed abiraterone before the company was sold to Johnson & Johnson in 2009. Auerbach brought many Cougar employees with him after founding Puma in 2010.
Funding for development
In August 2011 Puma licensed two drug candidates from Pfizer: neratinib (PB272) and an analog (PB357) to serve as a backup candidate.
As part of an approximately $60 million financing round in October 2011, Puma entered into a reverse merger with the shell company Innovative Acquisitions Corp., formed in 2007. In April 2012 the company's stock began trading over the counter. In October 2012 the company raised around $138 million and its shares were listed on the New York Stock Exchange.
In 2016 Puma discovered that Robert Gadimian, senior director of regulatory affairs, had twice bought and sold stock based on his knowledge of unpublished clinical trial results; Puma quickly fired him after conducting an internal investigation and reported the insider trading to the SEC.
Approval and licensing of neratinib
In March 2016 Puma held a pre-NDA meeting with the FDA in which the FDA raised concerns about the design and conduct of clinical trials that Puma had run and recommended that Puma not file the NDA with that data.
Puma did file the NDA, and in May 2017 an FDA review panel recommended that the FDA approve neratinib but raised concerns that the intended use was too broad and should be limited to people with specific mutations. The FDA's briefing document to the panel had raised concerns about the marginal benefit of the drug and the side effects. In July 2017 the FDA approved neratinib for use in preventing the return of breast cancer after treatment that included trastuzumab and without any need for genetic testing, and with warnings about the risk of severe diarrhea. U.S. sales of neratinib totaled $200.5 million in 2018.
In January 2018 an EMA committee gave a negative review to neratinib. In June 2018 this same EMA committee recommended the approval of neratinib, which received European Commission (EC) approval in September 2018.
In 2019 Puma licensed commercialization rights in Europe and part of Africa to Pierre Fabre for an upfront payment of $60 million and milestone payments that could reach $345 million. Previously, Puma licensed rights in Greater China to CANbrdige Life Sciences, rights in Israel to Medison Pharma, rights in Canada to Knight Therapeutics, rights in South East Asian to Specialised Therapeutics and rights in Latin America to Pint Pharma.
== References ==
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
PBYI Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$9.41
Kapitalizacja Rynkowa
$479M
P/E (TTM)
15.6
EPS (TTM)
$0.61
Przychody (TTM)
$228M
Stopa dywidendy
—
ROE
26.5%
D/E Dług/Kapitał
0.2
Zakres 52 tyg.
$4 – $10
PBYI Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$228M
2017-12-31
→
2025-12-31
EPS
$0.61
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$42M
2016-12-31
→
2025-12-31
Marże
13.6%
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
PBYI
Mediana porównawcza
P/E (TTM)
15.6
17.4
P/S (TTM)
2.1
52.3
P/B
3.7
4.8
EV / EBITDA
10.8
—
Price / FCF (Cena / FCF)
11.5
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
PBYI
Mediana porównawcza
Operating Margin (Marża Operacyjna)
16.3%
—
Net Profit Margin (Marża Zysku Netto)
13.6%
-670.1%
ROA
14.5%
-41.1%
ROE
26.5%
-52.6%
ROIC
21.2%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
PBYI
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
0.2
—
Current Ratio (Wskaźnik bieżący)
2.0
7.7
Quick Ratio (Wskaźnik Szybkości)
1.9
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
PBYI
Mediana porównawcza
Revenue YoY (Przychody R/R)
-0.91%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
0.05%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
0.29%
—
EPS YoY
-1.6%
—
Net Income YoY (Zysk Netto R/R)
2.8%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
PBYI
Mediana porównawcza
PBYI Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
SPRZEDAJ
6 analityków
- Mocne kupno 0 0,0%
- Kup 0 0,0%
- Trzymaj 3 50,0%
- Sprzedaj 1 16,7%
- Mocna sprzedaż 2 33,3%
12-miesięczny cel cenowy
1 analityków · 2026-08-18
Niski
$6.00
Wysoki
$6.00
Średni cel
$6.00
-36,2%
Średnia cel
$6.00
-36,2%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.07%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $0.16 | $0.04 | 0.12% |
| 31 marca 2026 | $-0.07 | $-0.13 | 0.06% |
| 31 grudnia 2025 | $0.26 | $0.23 | 0.03% |
| 30 września 2025 | $0.17 | $0.05 | 0.12% |
| 30 czerwca 2025 | $0.12 | $0.10 | 0.02% |
| 31 marca 2025 | $0.06 | $-0.02 | 0.08% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| QTTB | $43M | 1.4 | — | 55.5% | 200.3% | — |
| OCGN | $422M | -5.6 | 8.8% | -1537.4% | 1488.8% | — |
| LRMR | $317M | -2.2 | — | — | -167.4% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| CMPX | $958M | — | — | — | -45.9% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Cost of Revenue | $58M | $64M | $63M | $55M | $64M | $39M | $37M | $35M | $6M | |
| R&D Expense | · | · | · | · | $72M | $98M | $133M | $165M | $208M | |
| SG&A Expense | $71M | $80M | $90M | $90M | $116M | $118M | $142M | $146M | $107M | |
| Operating Expenses | $191M | $200M | $203M | $204M | $252M | $256M | $311M | $346M | $320M | |
| Operating Income | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M | |
| Interest Expense | · | · | $13M | $12M | $13M | $14M | $15M | $11M | $720.0K | |
| Interest Income | $4M | $5M | $3M | $813.0K | $160.0K | $489.0K | $3M | $2M | $1M | |
| Other Non-op | $1M | $862.0K | $759.0K | $-28.0K | $292.0K | $367.0K | $128.0K | $-714.0K | $-101.0K | |
| Pretax Income | $36M | $24M | $23M | $457.0K | $-29M | $-60M | $-76M | $-114M | · | |
| Income Tax | $5M | $-6M | $1M | $455.0K | $324.0K | $207.0K | $53.0K | $17.0K | $0 | |
| Net Income | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| EPS (Basic) | $0.62 | $0.62 | $0.46 | $0.00 | $-0.72 | $-1.52 | $-75595.00 | · | · | |
| EPS (Diluted) | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 | $-1.52 | · | · | · | |
| Shares (Basic) | 50,011,485 | 48,648,701 | 47,134,331 | 44,674,501 | 40,638,852 | 39,576,107 | · | · | · | |
| Shares (Diluted) | 50,653,283 | 49,100,433 | 47,550,852 | 44,929,998 | 40,638,852 | 39,576,107 | · | · | · | |
| EBITDA | $37M | $31M | $33M | $24M | $1M | $-30M | $-39M | $-95M | $-292M |
Bilans 26
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $69M | $85M | $76M | $63M | $85M | $60M | $108M | $82M | |
| Short-term Investments | $68M | $32M | $11M | $5M | $19M | $8M | $52M | $57M | · | |
| Receivables | $54M | $32M | $48M | $40M | $33M | $26M | $29M | $21M | $10M | |
| Inventory | $6M | $9M | $7M | $5M | $7M | $3M | $3M | $3M | $2M | |
| Prepaid Expense | $4M | $6M | $4M | $6M | $9M | $11M | $13M | $12M | $13M | |
| Other Current Assets | $256.0K | $91.0K | $912.0K | $2M | $447.0K | $4M | $323.0K | $2M | · | |
| Current Assets | $163M | $148M | $156M | $134M | $140M | $146M | $166M | $203M | $106M | |
| PP&E (Net) | $187.0K | $515.0K | $855.0K | $1M | $2M | $2M | $3M | $4M | $4M | |
| PP&E (Gross) | $5M | $8M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | |
| Accum. Depreciation | $5M | $8M | $8M | $7M | $7M | $6M | $6M | $5M | $4M | |
| Intangibles | $41M | $51M | $61M | $71M | $66M | $74M | $40M | $44M | $48M | |
| Total Assets | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Accounts Payable | $5M | $6M | $7M | $6M | $11M | $12M | $19M | $21M | $28M | |
| Accrued Liabilities | $50M | $37M | $53M | $53M | $93M | $61M | $69M | $46M | $31M | |
| Current Liabilities | $81M | $96M | $99M | $77M | $110M | $114M | $91M | $67M | $58M | |
| Capital Leases | $5M | $1M | $7M | $12M | $16M | $20M | $23M | · | · | |
| Other Non-current Liabilities | $0 | $121.0K | $121.0K | · | · | · | · | · | · | |
| Total Liabilities | $86M | $121M | $177M | $200M | $229M | $250M | $217M | $225M | $112M | |
| Long-term Debt | $23M | $68M | $102M | $102M | $102M | $84M | $95M | $152M | $48M | |
| Total Debt | $23M | $67M | $100M | $98M | $97M | $98M | · | · | · | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-1.28B | $-1.31B | $-1.35B | $-1.37B | $-1.37B | $-1.34B | $-1.28B | $-1.20B | $-1.09B | |
| AOCI | $36.0K | $6.0K | $-4.0K | $0 | $-2.0K | $0 | $62.0K | $-12.0K | · | |
| Stockholders' Equity | $130M | $92M | $53M | $22M | $-2M | $-6M | $17M | $34M | $53M | |
| Liabilities + Equity | $216M | $213M | $231M | $222M | $227M | $244M | $235M | $259M | $166M | |
| Shares Outstanding | 50,408,023 | 49,105,834 | 47,646,787 | 46,345,660 | 41,175,507 | 40,086,387 | 39,203,304 | 38,325,037 | 37,594,851 |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $11M | $12M | $12M | $10M | $11M | $10M | $8M | $7M | $3M | |
| Stock-based Comp | $7M | $8M | $10M | $12M | $33M | $37M | $57M | $87M | $109M | |
| Deferred Tax | $3M | $-7M | $0 | $0 | · | · | · | · | · | |
| Amort. of Intangibles | $10M | $10M | $8M | $8M | $8M | $6M | $4M | $4M | $2M | |
| Operating Cash Flow | $42M | $39M | $27M | $-16M | $21M | $773.0K | $22M | $-24M | $-172M | |
| CapEx | $71.0K | $56.0K | $140.0K | $0 | $0 | $46.0K | $306.0K | $439.0K | $431.0K | |
| Investing Cash Flow | $-36M | $-20M | $-19M | $7M | $-11M | $33M | $5M | $-58M | $-15M | |
| Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Net Debt Issued | · | · | · | · | · | · | $25M | $105M | $50M | |
| Financing Cash Flow | $-45M | $-34M | $0 | $12M | $-32M | $-10M | $-67M | $108M | $75M | |
| Net Change in Cash | $-40M | $-15M | $8M | $4M | $-22M | $24M | $-40M | $27M | $-113M | |
| Taxes Paid | $1M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $42M | $39M | $27M | $-16M | $21M | · | · | $-25M | $-173M | |
| Levered FCF | · | · | $14M | $-16M | $8M | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| Net Margin | 13.6% | 13.1% | 9.2% | 0.00% | -11.5% | -26.7% | -27.8% | -45.2% | -1054.6% | |
| Pretax Margin | 15.7% | 10.5% | 9.6% | 0.20% | -11.4% | -26.6% | · | · | · | |
| EBITDA Margin | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% | -13.5% | -14.4% | -37.7% | -1056.1% | |
| ROA | 14.5% | 13.6% | 9.5% | 0.00% | -12.4% | -25.0% | -30.6% | -53.5% | -139.6% | |
| ROE | 26.5% | 37.1% | 46.8% | 0.01% | 435.8% | 1873.7% | -436.4% | -283.2% | -221.9% | |
| ROIC | 21.2% | 24.4% | 20.3% | 0.09% | 1.4% | -33.0% | · | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 | 1.3 | 1.8 | 3.0 | 1.8 | |
| Quick Ratio | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 | 1.0 | 1.5 | 2.8 | 1.6 | |
| Debt / Equity | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 | -16.5 | · | · | · | |
| LT Debt / Equity | 0.0 | 0.2 | 1.2 | 4.5 | -39.7 | -14.1 | · | · | · | |
| Interest Coverage | · | · | 2.4 | 2.0 | 0.1 | -2.2 | -2.6 | -8.6 | -406.1 |
Efektywność 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.1 | 1.0 | 1.0 | 1.0 | 1.1 | 0.9 | 1.1 | 1.2 | 0.1 | |
| Inventory Turnover | 8.2 | 8.2 | 10.8 | 9.5 | 12.1 | · | · | 14.9 | 5.5 | |
| Receivables Turnover | 5.3 | 5.8 | 5.3 | 6.3 | 8.7 | 8.3 | 11.0 | 16.5 | 5.7 |
Stopy Wzrostu 6
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -0.91% | -2.2% | 3.3% | -9.9% | 12.5% | · | · | · | · | |
| Revenue CAGR 3Y | 0.05% | -3.1% | 1.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.29% | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.6% | 37.8% | · | · | · | · | · | · | · | |
| Net Income YoY | 2.8% | 40.2% | 1079450.0% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 2396.3% | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $228M | $230M | $236M | $228M | $253M | $225M | $272M | $251M | $28M | |
| Net Income TTM | $31M | $30M | $22M | $2.0K | $-29M | $-60M | $-76M | $-114M | $-292M | |
| Market Cap | $300M | $150M | $206M | $174M | $122M | $411M | $343M | $780M | $3.72B | |
| Enterprise Value | $225M | $116M | $210M | $191M | $137M | $416M | · | · | · | |
| P/E | 9.8 | 4.9 | 9.6 | · | -4.2 | -6.8 | · | · | · | |
| P/S | 1.3 | 0.6 | 0.9 | 0.8 | 0.5 | 1.8 | 1.3 | 3.1 | 134.2 | |
| P/B | 2.3 | 1.6 | 3.9 | 8.1 | -49.8 | -69.1 | 19.6 | 22.7 | 69.7 | |
| P / Tangible Book | 3.4 | 3.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 7.2 | 3.8 | 7.6 | -11.0 | 5.9 | 532.1 | 15.3 | -32.4 | -21.5 | |
| P / FCF | 7.2 | 3.9 | 7.7 | -11.0 | 5.9 | · | · | -31.8 | -21.5 | |
| EV / EBITDA | 6.0 | 3.7 | 6.4 | 8.1 | 106.1 | -13.7 | · | · | · | |
| EV / FCF | 5.4 | 3.0 | 7.8 | -12.1 | 6.6 | · | · | · | · | |
| EV / Revenue | 1.0 | 0.5 | 0.9 | 0.8 | 0.5 | 1.8 | · | · | · | |
| Earnings Yield | 10.2% | 20.3% | 10.4% | 0.00% | -23.7% | -14.8% | · | · | · |
Rachunek zysków i strat 16
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $57M | $45M | $75M | $54M | $52M | $46M | $59M | $81M | $47M | $44M | $72M | $56M | $55M | $53M | $66M | $57M | |
| Cost of Revenue | $12M | $10M | $23M | $12M | $12M | $11M | $14M | $29M | $11M | $11M | $24M | $13M | $12M | $13M | $17M | $12M | |
| SG&A Expense | $18M | $18M | $18M | $17M | $18M | $18M | $17M | $17M | $25M | $22M | $20M | $23M | $24M | $22M | $25M | $24M | |
| Operating Expenses | $49M | $49M | $58M | $45M | $46M | $42M | $46M | $58M | $49M | $46M | $57M | $48M | $50M | $48M | $56M | $55M | |
| Operating Income | $8M | $-4M | $17M | $10M | $7M | $4M | $13M | $22M | $-2M | $-2M | $15M | $9M | $5M | $4M | $10M | $2M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $831.0K | $1M | $977.0K | $1M | $956.0K | $1M | $1M | $1M | $1M | $972.0K | $719.0K | $689.0K | $660.0K | $537.0K | $519.0K | $216.0K | |
| Other Non-op | $9.0K | $130.0K | $143.0K | $115.0K | $410.0K | $359.0K | $268.0K | $347.0K | $156.0K | $91.0K | $641.0K | $74.0K | $86.0K | $-42.0K | $-204.0K | $64.0K | |
| Pretax Income | $8M | $-3M | $17M | $9M | $6M | $3M | $12M | $21M | $-4M | $-5M | $13M | $6M | $2M | $2M | $-5M | $-293.0K | |
| Income Tax | · | · | · | · | · | · | $-7M | $291.0K | $378.0K | $220.0K | $536.0K | $213.0K | $187.0K | $147.0K | $294.0K | $67.0K | |
| Net Income | $8M | $-4M | $13M | $9M | $6M | $3M | $19M | $20M | $-5M | $-5M | $12M | $6M | $2M | $1M | $-6M | $-360.0K | |
| EPS (Basic) | $0.16 | $-0.07 | $0.26 | $0.18 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.26 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| EPS (Diluted) | $0.16 | $-0.07 | $0.26 | $0.17 | $0.12 | $0.06 | $0.40 | $0.41 | $-0.09 | $-0.10 | $0.25 | $0.12 | $0.05 | $0.03 | $-0.12 | $-0.01 | |
| Shares (Basic) | 50,939,946 | 50,845,130 | -99,623,885 | 50,339,456 | 49,700,217 | 49,595,697 | -96,841,433 | 49,008,464 | 48,292,414 | 48,189,256 | -93,781,152 | 47,520,338 | 46,759,062 | 46,636,083 | -88,159,871 | 45,567,739 | |
| Shares (Diluted) | 52,596,589 | 50,845,130 | -100,327,655 | 50,929,893 | 50,144,704 | 49,906,341 | -96,554,598 | 49,173,361 | 48,292,414 | 48,189,256 | -94,627,471 | 47,819,234 | 47,201,185 | 47,157,904 | -88,204,189 | 45,567,739 | |
| EBITDA | $8M | $-4M | · | $10M | $7M | · | · | $22M | $-2M | $-2M | · | $9M | $5M | $4M | · | $2M |
Bilans 26
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $37M | $36M | $30M | $54M | $55M | $63M | $69M | $67M | $67M | $77M | · | $82M | $60M | $61M | · | $78M | |
| Short-term Investments | $57M | $65M | $68M | $41M | $41M | $30M | $32M | $29M | $30M | $30M | · | $3M | $14M | $10M | · | $0 | |
| Receivables | $34M | $26M | $54M | $34M | $26M | $25M | $32M | $55M | $28M | $25M | · | $29M | $31M | $31M | · | $28M | |
| Inventory | $13M | $9M | $6M | $9M | $9M | $9M | $9M | $3M | $9M | $7M | · | $6M | $8M | $4M | · | $5M | |
| Prepaid Expense | $4M | $3M | $4M | $4M | $4M | $5M | $6M | $3M | $3M | $4M | · | $4M | $5M | $5M | · | $7M | |
| Other Current Assets | $199.0K | $196.0K | $256.0K | $230.0K | $73.0K | $98.0K | $91.0K | $236.0K | $241.0K | $255.0K | · | $2M | $573.0K | $449.0K | · | $4M | |
| Current Assets | $145M | $142M | $163M | $144M | $137M | $133M | $148M | $157M | $138M | $143M | · | $125M | $119M | $112M | · | $122M | |
| PP&E (Net) | $103.0K | $124.0K | $187.0K | $305.0K | $388.0K | $474.0K | $515.0K | $601.0K | $680.0K | $757.0K | · | $907.0K | $977.0K | $1M | · | $1M | |
| PP&E (Gross) | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $9M | |
| Accum. Depreciation | $3M | $3M | $5M | $7M | $8M | $8M | $8M | $8M | $8M | $8M | · | $8M | $8M | $8M | · | $7M | |
| Intangibles | · | · | $41M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Assets | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Accounts Payable | $3M | $8M | $5M | $6M | $5M | $6M | $6M | $8M | $14M | $9M | · | $5M | $8M | $9M | · | $15M | |
| Accrued Liabilities | $45M | $38M | $50M | $37M | $32M | $27M | $37M | $51M | $39M | $38M | · | $34M | $35M | $34M | · | $40M | |
| Current Liabilities | $50M | $60M | $81M | $83M | $79M | $87M | $96M | $110M | $104M | $98M | · | $67M | $60M | $48M | · | $60M | |
| Capital Leases | $4M | $5M | $5M | $5M | $0 | $0 | $1M | $3M | $4M | $6M | · | $8M | $10M | $11M | · | $13M | |
| Other Non-current Liabilities | · | · | $0 | $0 | $0 | $0 | $121.0K | $121.0K | $121.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $54M | $64M | $86M | $88M | $90M | $99M | $121M | $150M | $156M | $163M | · | $165M | $170M | $170M | · | $177M | |
| Long-term Debt | $0 | $11M | $23M | $34M | $45M | $57M | $67M | $79M | $91M | $102M | · | $102M | $102M | $102M | · | $102M | |
| Total Debt | $0 | $11M | · | $34M | $45M | · | · | $78M | $89M | $100M | · | $99M | $99M | $99M | · | $98M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | · | $5.0K | $5.0K | $5.0K | · | $5.0K | |
| Retained Earnings | $-1.28B | $-1.29B | $-1.28B | $-1.30B | $-1.31B | $-1.31B | $-1.31B | $-1.33B | $-1.35B | $-1.35B | · | $-1.36B | $-1.36B | $-1.37B | · | $-1.36B | |
| AOCI | $-45.0K | $-31.0K | $36.0K | $19.0K | $-14.0K | $-11.0K | $6.0K | $26.0K | $-32.0K | $-26.0K | · | $-4.0K | $-6.0K | · | · | $0 | |
| Stockholders' Equity | $139M | $128M | $130M | $115M | $105M | $97M | $92M | $71M | $49M | $51M | $53M | $39M | $30M | $26M | $22M | $22M | |
| Liabilities + Equity | $193M | $193M | $216M | $203M | $195M | $196M | $213M | $221M | $205M | $214M | · | $204M | $200M | $196M | · | $199M | |
| Shares Outstanding | 51,102,687 | 50,879,204 | 50,408,023 | 50,384,274 | 49,892,725 | 49,615,174 | 49,105,834 | 49,067,348 | 48,460,120 | 48,214,663 | 47,646,787 | 47,542,790 | 46,947,153 | 46,663,599 | 46,345,660 | 45,608,814 |
Przepływy pieniężne 9
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $800.0K | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $2M | $15M | $14M | $10M | $14M | $4M | $16M | $11M | $1M | $11M | $10M | $11M | $3M | $3M | $8M | $17M | |
| CapEx | $0 | $0 | $-36.0K | $26.0K | $20.0K | $61.0K | $16.0K | $20.0K | $20.0K | $0 | $45.0K | $27.0K | · | · | $0 | $0 | |
| Investing Cash Flow | $8M | $2M | $-27M | $506.0K | $-11M | $2M | $-2M | $259.0K | $703.0K | $-19M | $-8M | $11M | $-5M | $-17M | $-12M | $8M | |
| Financing Cash Flow | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $-11M | $0 | $0 | $0 | $0 | $0 | $2M | $-53.0K | |
| Net Change in Cash | $-2M | $7M | $-24M | $-1M | $-8M | $-6M | $2M | $114.0K | $-10M | $-8M | $2M | $22M | $-1M | $-15M | $-2M | $25M | |
| Free Cash Flow | · | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność 7
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| Net Margin | 14.5% | -8.4% | · | 16.2% | 11.2% | · | · | 25.2% | -9.6% | -11.0% | · | 10.3% | 3.9% | 2.6% | · | -0.63% | |
| Pretax Margin | 14.6% | -7.6% | · | 17.0% | 11.8% | · | · | 25.6% | -8.8% | -10.5% | · | 10.7% | 4.2% | 2.9% | · | -0.51% | |
| EBITDA Margin | 13.4% | -8.5% | · | 17.6% | 12.7% | · | · | 27.4% | -4.6% | -5.2% | · | 15.3% | 9.0% | 8.3% | · | 4.2% | |
| ROA | 4.2% | -1.9% | · | 4.2% | 2.9% | · | · | 9.6% | -2.2% | -2.4% | · | 2.9% | 1.1% | 0.71% | · | -0.17% | |
| ROE | 6.7% | -3.3% | · | 9.5% | 7.6% | · | · | 37.0% | -11.5% | -12.5% | · | 19.0% | 8.5% | 8.5% | · | -6.4% | |
| ROIC | · | · | · | · | · | · | · | 14.6% | -1.7% | -1.6% | · | 6.0% | 3.5% | 3.2% | · | 2.5% |
Płynność i wypłacalność 5
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.9 | 2.4 | · | 1.7 | 1.7 | · | · | 1.4 | 1.3 | 1.5 | · | 1.9 | 2.0 | 2.3 | · | 2.0 | |
| Quick Ratio | 2.6 | 2.1 | · | 1.5 | 1.5 | · | · | 1.4 | 1.2 | 1.3 | · | 1.7 | 1.8 | 2.1 | · | 1.8 | |
| Debt / Equity | 0.0 | 0.1 | · | 0.3 | 0.4 | · | · | 1.1 | 1.8 | 2.0 | · | 2.6 | 3.3 | 3.8 | · | 4.4 | |
| LT Debt / Equity | 0.0 | 0.0 | · | 0.0 | 0.1 | · | · | 0.5 | 0.9 | 1.1 | · | 2.0 | 2.9 | 3.8 | · | 4.4 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -0.7 | · | 2.6 | 1.5 | 1.3 | · | 0.8 |
Efektywność 3
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.3 | · | · | 0.4 | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Inventory Turnover | 1.1 | 1.2 | · | 2.0 | 1.4 | · | · | 7.0 | 1.3 | 2.0 | · | 2.4 | 1.7 | 2.4 | · | 2.0 | |
| Receivables Turnover | 1.9 | 1.7 | · | 1.2 | 1.9 | · | · | 1.9 | 1.6 | 1.6 | · | 2.0 | 1.7 | 1.8 | · | 2.2 |
Wycena (TTM) 14
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $208M | $198M | · | $233M | $226M | $217M | · | $228M | $202M | $207M | · | $221M | $224M | $215M | · | $209M | |
| Net Income TTM | $19M | $14M | · | $38M | $25M | $14M | · | $17M | $-1M | $5M | · | $9M | $13M | $7M | · | $-39M | |
| Market Cap | $414M | $325M | · | $268M | $171M | · | · | $125M | $158M | $256M | · | $125M | $166M | $144M | · | $108M | |
| Enterprise Value | $321M | $235M | · | $207M | $120M | · | · | $106M | $150M | $248M | · | $139M | $190M | $172M | · | $128M | |
| P/E | 21.3 | 22.8 | · | 7.0 | 6.9 | 10.6 | · | 7.5 | -163.0 | 53.0 | · | 13.8 | 12.6 | 20.6 | · | -2.4 | |
| P/S | 2.0 | 1.6 | · | 1.1 | 0.8 | · | · | 0.6 | 0.8 | 1.2 | · | 0.6 | 0.7 | 0.7 | · | 0.5 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 1.6 | · | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Tangible Book | 3.0 | 2.5 | · | 2.3 | 1.6 | 1.5 | · | 1.8 | 3.3 | 5.0 | · | 3.2 | 5.5 | 5.6 | · | 4.9 | |
| P / Cash Flow | · | 21.1 | · | · | · | · | · | · | · | 22.7 | · | · | · | 54.6 | · | · | |
| P / FCF | · | 21.1 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / EBITDA | 42.3 | -61.4 | · | 21.6 | 18.1 | · | · | 4.8 | -68.9 | -108.0 | · | 16.2 | 38.9 | 39.3 | · | 53.5 | |
| EV / FCF | · | 15.2 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 1.5 | 1.2 | · | 0.9 | 0.5 | · | · | 0.5 | 0.7 | 1.2 | · | 0.6 | 0.8 | 0.8 | · | 0.6 | |
| Earnings Yield | 4.7% | 4.4% | · | 14.3% | 14.6% | 9.5% | · | 13.3% | -0.61% | 1.9% | · | 7.2% | 7.9% | 4.9% | · | -40.9% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $228M | $230M | $236M | $228M | $253M |
| Marża Operacyjna % | 16.3% | 13.4% | 13.9% | 10.4% | 0.51% |
| Zysk netto | $31M | $30M | $22M | $2.0K | $-29M |
| Rozwodniony EPS | $0.61 | $0.62 | $0.45 | $0.00 | $-0.72 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.2 | 0.7 | 1.9 | 4.5 | -39.7 |
| Wskaźnik bieżący | 2.0 | 1.5 | 1.6 | 1.7 | 1.3 |
| Wskaźnik Szybkości | 1.9 | 1.4 | 1.4 | 1.6 | 1.0 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $42M | $39M | $27M | $-16M | $21M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 173 emitenci · $239.8M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 28 (+2 vs poprzedni kw.) | 15 (-2 vs poprzedni kw.) | 56 (+1 vs poprzedni kw.) | 47 (+7 vs poprzedni kw.) | +4.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| ACORN CAPITAL ADVISORS, LLC | $33 504 835 | 4 131 299 | 13,97% | Akcje |
| VANGUARD GROUP INC | $21 011 306 | 3 531 312 | 8,76% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $18 815 168 | 2 319 996 | 7,85% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $14 891 687 | 1 836 213 | 6,21% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $14 887 065 | 1 835 643 | 6,21% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $14 805 608 | 1 825 599 | 6,18% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $11 407 283 | 1 406 570 | 4,76% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $9 618 136 | 1 185 702 | 4,01% | Akcje |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $9 113 880 | 1 123 783 | 3,80% | Akcje |
| STATE STREET CORP | $7 722 058 | 952 165 | 3,22% | Akcje |
| KENNEDY CAPITAL MANAGEMENT LLC | $7 082 082 | 873 253 | 2,95% | Akcje |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $6 420 006 | 791 616 | 2,68% | Akcje |
| RITHOLTZ WEALTH MANAGEMENT | $6 080 862 | 749 798 | 2,54% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $5 214 292 | 642 946 | 2,17% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $4 884 166 | 602 240 | 2,04% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4 318 170 | 532 450 | 1,80% | Akcje |
| GLOBEFLEX CAPITAL L P | $3 104 565 | 382 807 | 1,29% | Akcje |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2 506 850 | 309 106 | 1,05% | Akcje |
| D. E. Shaw & Co., Inc. | $2 300 377 | 283 647 | 0,96% | Akcje |
| Russell Investments Group, Ltd. | $2 207 323 | 272 173 | 0,92% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $2 182 158 | 269 070 | 0,91% | Akcje |
| FEDERATED HERMES, INC. | $2 033 712 | 250 766 | 0,85% | Akcje |
| Empowered Funds, LLC | $1 786 763 | 220 316 | 0,75% | Akcje |
| PANAGORA ASSET MANAGEMENT INC | $1 764 290 | 217 545 | 0,74% | Akcje |
| GOLDMAN SACHS GROUP INC | $1 758 256 | 216 801 | 0,73% | Akcje |
| FMR LLC | $1 708 274 | 210 638 | 0,71% | Akcje |
| PRUDENTIAL FINANCIAL INC | $1 600 095 | 197 299 | 0,67% | Akcje |
| STATE OF WISCONSIN INVESTMENT BOARD | $1 526 562 | 188 232 | 0,64% | Akcje |
| Prospera Financial Services Inc | $1 287 530 | 158 762 | 0,54% | Akcje |
| Haven Private, LLC | $1 203 913 | 148 448 | 0,50% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $1 140 161 | 140 587 | 0,48% | Akcje |
| BlackRock, Inc. | $1 134 784 | 139 924 | 0,47% | Akcje |
| FIRST TRUST ADVISORS LP | $1 055 970 | 130 206 | 0,44% | Akcje |
| Bank of New York Mellon Corp | $1 048 964 | 129 342 | 0,44% | Akcje |
| Round Rock Advisors LLC | $1 045 476 | 128 912 | 0,44% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1 040 051 | 128 243 | 0,43% | Akcje |
| STRS OHIO | $686 106 | 84 600 | 0,29% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $596 085 | 73 500 | 0,25% | Akcje |
| Trexquant Investment LP | $585 729 | 72 223 | 0,24% | Akcje |
| Vise Technologies, Inc. | $584 163 | 72 030 | 0,24% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $520 662 | 64 200 | 0,22% | Opcja kupna |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $497 000 | 61 255 | 0,21% | Akcje |
| OpenArc Corporate Advisory, LLC | $482 472 | 59 491 | 0,20% | Akcje |
| RHUMBLINE ADVISERS | $466 397 | 57 510 | 0,19% | Akcje |
| TWO SIGMA ADVISERS, LP | $423 045 | 71 100 | 0,18% | Akcje |
| D'Orazio & Associates, Inc. | $394 795 | 48 680 | 0,16% | Akcje |
| Vanguard Global Advisers, LLC | $375 225 | 46 267 | 0,16% | Akcje |
| DEUTSCHE BANK AG\ | $350 287 | 43 192 | 0,15% | Akcje |
| Man Group plc | $336 614 | 41 506 | 0,14% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $333 240 | 41 090 | 0,14% | Akcje |
| WINTON GROUP Ltd | $328 528 | 40 509 | 0,14% | Akcje |
| XTX Topco Ltd | $326 801 | 40 296 | 0,14% | Akcje |
| State of Wyoming | $323 046 | 39 833 | 0,13% | Akcje |
| WELLS FARGO & COMPANY/MN | $304 977 | 37 605 | 0,13% | Akcje |
| EntryPoint Capital, LLC | $303 200 | 37 386 | 0,13% | Akcje |
| Baron Wealth Management LLC | $294 977 | 36 372 | 0,12% | Akcje |
| Creative Planning | $289 827 | 35 737 | 0,12% | Akcje |
| LPL Financial LLC | $280 095 | 34 537 | 0,12% | Akcje |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $279 673 | 34 485 | 0,12% | Akcje |
| BANK OF AMERICA CORP /DE/ | $257 468 | 31 747 | 0,11% | Akcje |
| Kathmere Capital Management, LLC | $252 805 | 31 172 | 0,11% | Akcje |
| FRANKLIN RESOURCES INC | $242 165 | 29 860 | 0,10% | Akcje |
| ENVESTNET ASSET MANAGEMENT INC | $236 731 | 29 190 | 0,10% | Akcje |
| Y-Intercept (Hong Kong) Ltd | $212 660 | 26 222 | 0,09% | Akcje |
| MARTINGALE ASSET MANAGEMENT L P | $205 703 | 25 364 | 0,09% | Akcje |
| Metis Global Partners, LLC | $204 891 | 25 264 | 0,09% | Akcje |
| MetLife Investment Management, LLC | $201 720 | 24 873 | 0,08% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $195 451 | 24 100 | 0,08% | Opcja sprzedaży |
| C2C Wealth Management, LLC | $191 558 | 23 620 | 0,08% | Akcje |
| Nuveen, LLC | $187 982 | 23 179 | 0,08% | Akcje |
| PRELUDE CAPITAL MANAGEMENT, LLC | $174 754 | 21 548 | 0,07% | Akcje |
| One Wealth Advisors, LLC | $170 951 | 21 079 | 0,07% | Akcje |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $165 306 | 20 383 | 0,07% | Akcje |
| CITIGROUP INC | $154 990 | 19 111 | 0,06% | Akcje |
| BAILARD, INC. | $146 791 | 18 100 | 0,06% | Akcje |
| Invesco Ltd. | $142 493 | 17 570 | 0,06% | Akcje |
| JANE STREET GROUP, LLC | $141 925 | 17 500 | 0,06% | Opcja kupna |
| Spark Investment Management LLC | $137 870 | 17 000 | 0,06% | Akcje |
| MORGAN STANLEY | $137 416 | 16 944 | 0,06% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $136 490 | 21 360 | 0,06% | Akcje |
| Brandywine Global Investment Management, LLC | $129 710 | 21 800 | 0,05% | Akcje |
| Police & Firemen's Retirement System of New Jersey | $127 481 | 15 719 | 0,05% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $125 510 | 15 476 | 0,05% | Akcje |
| Lido Advisors, LLC | $122 015 | 15 045 | 0,05% | Akcje |
| Mariner, LLC | $120 593 | 14 869 | 0,05% | Akcje |
| Caprock Group, LLC | $112 421 | 13 862 | 0,05% | Akcje |
| PERKINS CAPITAL MANAGEMENT INC | $108 674 | 13 400 | 0,05% | Akcje |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | $107 960 | 13 312 | 0,05% | Akcje |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $105 624 | 13 203 | 0,04% | Akcje |
| UBS Group AG | $99 923 | 12 321 | 0,04% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $97 774 | 12 056 | 0,04% | Akcje |
| CWM, LLC | $97 531 | 15 263 | 0,04% | Akcje |
| R Squared Ltd | $97 247 | 11 991 | 0,04% | Akcje |
| Abel Hall, LLC | $93 427 | 11 520 | 0,04% | Akcje |
| IEQ CAPITAL, LLC | $86 542 | 10 671 | 0,04% | Akcje |
| Williams & Novak, LLC | $85 066 | 10 489 | 0,04% | Akcje |
| Vanguard Personalized Indexing Management, LLC | $84 409 | 10 408 | 0,04% | Akcje |
| Ethic Inc. | $83 290 | 10 270 | 0,03% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $83 136 | 10 251 | 0,03% | Akcje |
| INTECH INVESTMENT MANAGEMENT LLC | $82 803 | 10 210 | 0,03% | Akcje |
Insiderzy spółki 24 insiderów · 10 dyrektorzy generalni · 12 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Alan H Auerbach | President and CEO | 6 lipca 2026 S | 7 261 671 | 0 | 1 | $-363 919 |
| Maximo F Nougues | Chief Financial Officer | 6 lipca 2026 S | 230 637 | 0 | 1 | $-77 528 |
| Douglas M Hunt | The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | 6 lipca 2026 S | 196 841 | 0 | 1 | $-69 880 |
| Alvin F Wong | Chief Scientific Officer | 17 czerwca 2021 A | — | 0 | 0 | $0 |
| Richard Paul Bryce | Title of Reporting Person: Chief Medical and Scientific Officer | 5 kwietnia 2021 S | 121 662 | 0 | 0 | $0 |
| Jeffrey Jerome Ludwig | Chief Commercial Officer | 17 lutego 2021 A | 36 069 | 0 | 0 | $0 |
| Steven Lo | Chief Commercial Officer | 22 lipca 2019 S | 19 557 | 0 | 0 | $0 |
| Charles R Eyler | Title of Reporting Person: Senior Vice President, Finance and Administration and Treasurer | 4 lutego 2019 S | 31 957 | 0 | 0 | $0 |
| Robert Charnas | The Reporting Person is the Senior Vice President of Regulatory Affairs and Project Management of the Issuer. | 16 lutego 2017 A | 26 453 | 0 | 0 | $0 |
| Richard Benton Phillips | The Reporting Person is the Interim Head of Regulatory Affairs, Quality Assurance and Pharmacovigilance of the Issuer. | 15 kwietnia 2016 A | — | 0 | 0 | $0 |
| Brian M Stuglik | Dyrektor | 12 czerwca 2026 S | 113 858 | 0 | 1 | $-58 320 |
| Allison Dorval | Dyrektor | 12 czerwca 2026 S | 90 780 | 0 | 1 | $-83 592 |
| Adrian Senderowicz | Dyrektor | 12 czerwca 2026 S | 27 000 | 0 | 1 | $-194 400 |
| Troy Edward Wilson | Dyrektor | 12 czerwca 2026 S | 59 750 | 0 | 1 | $-77 760 |
| Jay M Moyes | Dyrektor | 12 czerwca 2026 S | 58 322 | 0 | 1 | $-158 840 |
| Alessandra Cesano | Dyrektor | 11 czerwca 2026 A | 68 850 | 0 | 0 | $0 |
| MILLER MICHAEL PATRICK | Dyrektor | 11 czerwca 2026 A | 81 000 | 0 | 0 | $0 |
| Ann Calby Miller | Dyrektor | 15 czerwca 2021 A | 40 732 | 0 | 0 | $0 |
| Hugh O'Dowd | Dyrektor | 9 czerwca 2020 A | 25 748 | 0 | 0 | $0 |
| Frank Zavrl | Dyrektor | 9 czerwca 2020 A | 50 993 | 0 | 0 | $0 |
| Thomas Malley | Dyrektor | 15 grudnia 2014 A | 156 551 | 0 | 0 | $0 |
| Faraaz Siddiqi | — | 4 października 2011 D | 0 | 0 | 0 | $0 |
| Kapil Munjal | — | 4 października 2011 D | 0 | 0 | 0 | $0 |
| Robert Andrew Johnson | — | 4 października 2011 D | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 7 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Alan H. Auerbach ×6 zgłoszenia | 13 grudnia 2022 | — | Pierwotne zgłoszenie | — | SEC |
| Kapil Munjal 2) | 4 października 2011 | — | Pierwotne zgłoszenie | — | SEC |
| Faraaz Siddiqi 2) | 4 października 2011 | — | Pierwotne zgłoszenie | — | SEC |
| Robert Johnson 2) | 4 października 2011 | — | Pierwotne zgłoszenie | — | SEC |
| Robert Johnson | 21 listopada 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Niezgłoszona osoba raportująca | 19 listopada 2007 | — | Pierwotne zgłoszenie | — | SEC |
| Faraaz Siddiqi | 19 listopada 2007 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 36 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0,72% | 52 608 NS | 30 kwietnia 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,46% | 233 908 SH | 8 sierpnia 2026 | Dziennie |
| IWC · iShares Trust | 0,08% | 150 797 SH | 8 sierpnia 2026 | Dziennie |
| VFQY · VANGUARD WELLINGTON FUND | 0,06% | 34 260 SH | 8 sierpnia 2026 | Dziennie |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,05% | 1 924 360 NS | 31 maja 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 55 680 NS | 31 maja 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,03% | 2 746 SH | 8 sierpnia 2026 | Dziennie |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 95 559 NS | 31 maja 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 32 358 SH | 8 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | 0,02% | 356 623 SH | 8 sierpnia 2026 | Dziennie |
| BIB · ProShares Trust | 0,02% | 1 879 NS | 31 maja 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 55 064 SH | 8 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,01% | 1 153 241 SH | 8 sierpnia 2026 | Dziennie |
| RSSL · Global X Funds | 0,01% | 19 123 NS | 30 kwietnia 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,01% | 16 014 SH | 8 sierpnia 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 254 380 SH | 8 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 166 672 NS | 30 kwietnia 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 156 761 NS | 30 kwietnia 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,01% | 82 003 NS | 30 kwietnia 2026 | N-PORT |
| ITWO · ProShares Trust | 0,01% | 2 027 NS | 31 maja 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 3 611 NS | 30 kwietnia 2026 | N-PORT |
| EBI · RBB Fund Trust | 0,01% | 5 394 NS | 31 maja 2026 | N-PORT |
| UWM · ProShares Trust | 0,00% | 1 585 NS | 31 maja 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 65 370 SH | 8 sierpnia 2026 | Dziennie |
| URTY · ProShares Trust | 0,00% | 1 603 NS | 31 maja 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 2 071 NS | 31 maja 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 34 919 NS | 31 maja 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 6 348 NS | 30 kwietnia 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 40 NS | 31 maja 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 9 704 NS | 30 kwietnia 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 15 090 NS | 30 kwietnia 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 12 376 NS | 30 kwietnia 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 446 899 SH | 8 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 343 121 SH | 8 sierpnia 2026 | Dziennie |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 680 SH | 8 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 979 SH | 8 sierpnia 2026 | Dziennie |